Filter Results

Clinical Studies

Closed for Enrollment

  • ECOST = Economic and Clinical Outcomes of (whole exome) Sequencing in Tapestry (ECOST) Rochester, Minn., Scottsdale/Phoenix, Ariz.

    The overall hypothesis is that the early detection of genetic variants leads to early interventions in cancer development.  This will lead to lower rates of cancer development and will eventually result in lower death rate from cancer.  In the short term, healthcare utilization and costs will increase due to the early interventions and treatments.  In the long term, benefit will start to emerge due to the lower disease development, lower death rate, and retaining of the quality of life and life expectancy.
.